Clostridium spp. are a genus of Gram-positive, anaerobic bacteria that can cause a range of diseases, including botulism, tetanus, and gas gangrene. These pathogens produce potent toxins, which are often the target of diagnostic and therapeutic antibodies.

Types of Clostridium Antibodies

  • Neutralizing Antibodies: These antibodies specifically bind to and neutralize the toxins produced by Clostridium species. For instance:
    • Botulism Antitoxin: Neutralizes botulinum toxin produced by Clostridium botulinum.
    • Tetanus Antitoxin: Neutralizes tetanospasmin toxin produced by Clostridium tetani.
  • Diagnostic Antibodies: Used in immunoassays to detect Clostridium toxins or antigens in clinical samples. These include:
    • ELISA (Enzyme-Linked Immunosorbent Assay) Antibodies: Target specific Clostridium antigens for detection.
    • Western Blot Antibodies: Used to identify and characterize Clostridium proteins.
  • Therapeutic Antibodies: Used for treatment and include:
    • Monoclonal Antibodies: These are engineered to target specific epitopes of Clostridium toxins. For example, monoclonal antibodies against botulinum toxin can provide passive immunity.

Mechanism of Action

  • Neutralization: Clostridium antibodies bind to the active sites of toxins, preventing them from interacting with host cell receptors. This neutralization blocks the pathophysiological effects of the toxins.
  • Opsonization: Antibodies can tag Clostridium bacteria for phagocytosis by immune cells.
  • Agglutination: Antibodies can cause clumping of Clostridium cells, which facilitates their clearance by the immune system.

Production and Purification

  • Polyclonal Antibodies: Produced by immunizing animals (e.g., horses or rabbits) with Clostridium toxins or antigens. The sera are collected and processed to extract antibodies.
  • Monoclonal Antibodies: Produced using hybridoma technology, which involves fusing B cells with myeloma cells to create a hybridoma that produces a single type of antibody.

Clinical Applications

  • Prevention and Treatment: Clostridium antitoxins are used for prophylaxis and treatment of diseases like tetanus and botulism.
  • Diagnostic Tools: Clostridium-specific antibodies are used in laboratory assays to diagnose infections and measure immune responses.
570.00 570.0 USD
200.00 200.0 USD
AffiAB®​ Anti-Clostridium tetani Toxin Antibody
CAT# AFG-QDB-1253
Size: 500 μg
753.35 753.35 USD
692.45 692.45 USD
851.00 851.0 USD
851.00 851.0 USD
733.40 733.4 USD
625.20 625.2 USD
420.00 420.0 USD
380.40 380.40000000000003 USD
380.40 380.40000000000003 USD
380.40 380.40000000000003 USD
380.40 380.40000000000003 USD
380.40 380.40000000000003 USD
380.40 380.40000000000003 USD
380.40 380.40000000000003 USD
AffiAB® Human Anti- (C. difficile toxin B) mAb
CAT# AFG-BTB-095
Size: 100 μg
514.69 514.69 USD
AffiAB® Human Anti- (C. difficile toxin A) mAb
CAT# AFG-BTB-094
Size: 100 μg
514.69 514.69 USD
AffiAB® Chimeric Anti- (C. perfringens ETX) mAb
CAT# AFG-BTB-093
Size: 100 μg
514.69 514.69 USD
AffiAB® CLOSTRIDIUM DIFFICILE TOXIN B Antibody
CAT# AFG-IVA-06651
Size: 0.1 mg
Terminal: N/A
1,029.65 1029.65 USD
AffiAB® CLOSTRIDIUM DIFFICILE TOXIN A Antibody
CAT# AFG-IVA-06650
Size: 0.1 mg
Terminal: N/A
935.15 935.15 USD
AffiAB® Clostridium difficile Glutamate Dehydrogenase (GDH) Antibody
CAT# AFG-IVA-06649
Size: 1 mg T
erminal: N/A
1,132.25 1132.25 USD
AffiAB® C. difficile Toxin B Antibody
CAT# AFG-IVA-03661
Size: 1 mg T
erminal: N/A
1,556.15 1556.15 USD
AffiAB® C. difficile Toxin A Antibody
CAT# AFG-IVA-03660
Size: 1 mg T
erminal: N/A
1,556.15 1556.15 USD